Fundz

Novigenix Announces First Closing Of Its $20M Series B

PRIVATENov 16, 2022

Amount Raised

$20 Million

Round Type

Series B

LausanneBiotechnologyHealth Care

Description

LAUSANNE, SWITZERLAND / November 16, 2022 / Novigenix SA, a leading data-driven precision medicine biotech that develops and commercializes Immuno-Transcriptomic precision oncology solutions, today announced successful first closing of its $20 million Series B financing round with participation from existing and new investors.

Quick answer

Novigenix raised $20 Million in a Series B round, dated November 16, 2022. Novigenix is based in Lausanne, Vaud, Switzerland.

How much did Novigenix raise?
Novigenix raised $20 Million in a Series B round on November 16, 2022.
What does Novigenix do?
Novigenix is a precision medicine biotech providing a new understanding of the human host response to cancer and its response to therapy.
Where is Novigenix based and how big is it?
Novigenix is based in Lausanne, Vaud, Switzerland.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Novigenix that raised within 45 days of this round, from Fundz verified event records.

  • CytoSorbents Corporation raised $5M (Debt Financing) on December 29, 2022.
  • Cue Biopharma raised an undisclosed amount on December 27, 2022.
  • TRACON raised $30M (Grant) on December 27, 2022.
  • Endovia Health Sciences, Inc. raised $4M (Seed) on December 27, 2022.
  • PVmed raised $14M (Series A) on December 23, 2022.
  • GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.

Who to call at Novigenix, and when

A new round usually means Novigenix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Novigenix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Novigenix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Novigenix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Novigenix

Location

Lausanne, Vaud, Switzerland

About

Novigenix is a precision medicine biotech providing a new understanding of the human host response to cancer and its response to therapy. The Company was founded on the vision that Immuno-Transcriptomics will bring unprecedented advances in diagnosing and treating cancer patients, leading to significant improvement in healthcare. Novigenix's unique Immuno-Transcriptomic platform enables an accelerated identification of disease specific mRNA signatures of immune cells, which combined with machine learning and predictive algorithms provide new insights into onset and progression of disease. For more information visit www.novigenix.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Novigenix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Novigenix's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Novigenix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.